Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cushing’s syndrome due to interaction between ritonavir or cobicistat and corticosteroids: a case–control study in the French Pharmacovigilance Database
Laure Peyro‐Saint‐Paul, Paul Besnier, Ludivine Demessine, et al.
Journal of Antimicrobial Chemotherapy (2019) Vol. 74, Iss. 11, pp. 3291-3294
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The challenge of HIV treatment in an era of polypharmacy
David Back, Catia Marzolini
Journal of the International AIDS Society (2020) Vol. 23, Iss. 2
Open Access | Times Cited: 146
Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19
F. Lemaı̂tre, Klemens Budde, Teun van Gelder, et al.
Therapeutic Drug Monitoring (2022) Vol. 45, Iss. 2, pp. 191-199
Open Access | Times Cited: 47
Relevance of biomarkers indicating gut damage and microbial translocation in people living with HIV
Jing Ouyang, Jiangyu Yan, Xin Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
What we have to know about corticosteroids use during Sars-Cov-2 infection
Francesco Ferraù, Filippo Ceccato, Salvatore Cannavò, et al.
Journal of Endocrinological Investigation (2020) Vol. 44, Iss. 4, pp. 693-701
Open Access | Times Cited: 44
Long‐coronavirus disease among people living with HIV in western India: An observational study
Sanjay Pujari, Sunil Gaikwad, Abhishek Chitalikar, et al.
Immunity Inflammation and Disease (2021) Vol. 9, Iss. 3, pp. 1037-1043
Open Access | Times Cited: 33
Omega-3 Polyunsaturated Fatty Acids in Chronic Obstructive Pulmonary Disease Patients with COVID-19: A Review
Halliru Zailani, Senthil Kumaran Satyanarayanan, Wei‐Chih Liao, et al.
Current Nutrition Reports (2025) Vol. 14, Iss. 1
Closed Access
Polypharmacy-associated risk of hospitalisation among people ageing with and without HIV: an observational study
Amy C. Justice, Kirsha S. Gordon, Jonathon Romero, et al.
The Lancet Healthy Longevity (2021) Vol. 2, Iss. 10, pp. e639-e650
Open Access | Times Cited: 24
Human Immunodeficiency Virus in Older Adults
Matthew Russell, Amy C. Justice
Clinics in Geriatric Medicine (2024) Vol. 40, Iss. 2, pp. 285-298
Closed Access | Times Cited: 3
Inhalation of nebulized omega-3 fatty acids mitigate LPS-induced acute lung inflammation in rats: Implications for treatment of COPD and COVID-19
Chandrashekhar Kocherlakota, Banda Nagaraju, Arjun Narala, et al.
Prostaglandins Leukotrienes and Essential Fatty Acids (2022) Vol. 179, pp. 102426-102426
Open Access | Times Cited: 11
Iatrogenic Cushing’s Syndrome: The Result of Cobicistat and Glucocorticoid Interaction in an HIV Patient After Bariatric Surgery
Vânia Benido Silva, Joana Cardoso, Maria Esteves Brandão, et al.
Cureus (2023)
Open Access | Times Cited: 4
HIV and chronic lung disease
Janice M. Leung
Current Opinion in HIV and AIDS (2022) Vol. 18, Iss. 2, pp. 93-101
Closed Access | Times Cited: 6
Are unknown co-medications, over-the-counter and off-label drug use still problems among people living with HIV? Results from a transversal survey in 23 centres in France
Macha Tétart, Priscila Passecountrin, Anaïs Lesourd, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 11, pp. 2731-2734
Closed Access | Times Cited: 2
Clinical Relevance of Drug Interactions in People Living with Human Immunodeficiency Virus on Antiretroviral Therapy—Update 2022: Systematic Review
Pedro Amariles, Mónica Rivera-Cadavid, Mauricio Ceballos
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2488-2488
Open Access | Times Cited: 2
Ritonavir/Cobicistat-Induced Cushing Syndrome in HIV Patients Treated With Non-Oral Corticosteroids: A Call for Action?
Dario Cattaneo, Andrea Giacomelli, Gabriele Pagani, et al.
The American Journal of the Medical Sciences (2020) Vol. 361, Iss. 1, pp. 137-139
Closed Access | Times Cited: 4
Cushing's syndrome secondary to inhaled fluticasone
Álvaro Santaella Gómez, María José Amaya García, José María Rafael Saponi Cortés, et al.
Endocrinología Diabetes y Nutrición (English ed ) (2022) Vol. 69, Iss. 6, pp. 442-444
Closed Access | Times Cited: 3
Orthostatic hypotension in a patient with HIV: uncovering adrenal insufficiency from fluticasone–cobicistat interactions
Serena Dienes, Robert Nunn, Alison Lai
Canadian Medical Association Journal (2024) Vol. 196, Iss. 40, pp. E1341-E1344
Open Access
Iatrogenic Caushing syndrome caused by inhaled corticosteroids in an HIV+ patient
Eva Cabrera César, Álvaro Martínez Mesa, Alberto Levy Naón
Archivos de Bronconeumología (2020) Vol. 56, Iss. 2, pp. 121-122
Closed Access | Times Cited: 2
Iatrogenic recurrence of Kaposi sarcoma induced by the pharmacological interaction between periarticular injection of corticosteroids and ritonavir in a HIV ‐infected patient
Olivier Fakih, C. Drobacheff-Thiébaut, Laurent Hustache‐Mathieu, et al.
Dermatologic Therapy (2020) Vol. 34, Iss. 1
Open Access | Times Cited: 1
Síndrome de Cushing secundario a fluticasona inhalada
Álvaro Santaella Gómez, María José Amaya García, José María Rafael Saponi Cortés, et al.
Endocrinología Diabetes y Nutrición (2021) Vol. 69, Iss. 6, pp. 442-444
Closed Access | Times Cited: 1
Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug–drug interactions among HIV‐positive patients receiving treatment for coronavirus disease 2019 (COVID‐19)
Botond Lakatos, Justyna D. Kowalska, Sergii Antoniak, et al.
HIV Medicine (2021) Vol. 23, Iss. 6, pp. 693-700
Closed Access | Times Cited: 1
Drug–drug interactions between COVID-19 therapeutics and antiretroviral treatment: the evidence to date
C.J. Ellis, Keita Inaba, Christine Van de Vuurst, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 11, pp. 795-806
Closed Access
Cushing iatrógeno secundario al uso de corticoides inhalados en paciente VIH
Eva Cabrera César, Álvaro Martínez Mesa, Alberto Levy Naón
Archivos de Bronconeumología (2019) Vol. 56, Iss. 2, pp. 121-122
Closed Access
DDIs between corticosteroids and cobicistat or ritonavir

Reactions Weekly (2019) Vol. 1766, Iss. 1, pp. 6-6
Closed Access
Antiretrovirals/corticosteroids/verapamil

Reactions Weekly (2019) Vol. 1783, Iss. 1, pp. 48-48
Closed Access
Evaluation of the Efficacy of Omega-3 Fatty Acids Formulations in the Lipopolysaccharide-Induced Acute Lung Inflammation Rat Model
Chandrashekhar Kocherlakota, Nagaraju Banda, Arjun Narala, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Page 1 - Next Page

Scroll to top